| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | AMOXICILLIN | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | Phenylephrine HCl 40 mg Added to 0.9% Sodium Chloride 250 mL Bag | 6 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | These highlights do not include all the information needed to use Oxycodone Hydrochloride safely and effectively. See full prescribing information for Oxycodone Hydrochloride. Oxycodone Hydrochloride (Oxycodone Hydrochloride) SOLUTION for ORAL use. Initial U.S. Approval: 1950 | 4 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | AZITHROMYCIN MONOHYDRATE | 5 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | Phenylephrine HCl 30 mg Added to 0.9% Sodium Chloride 100 mL Bag | 4 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | Diltiazem HCl 250 mg in 5% Dextrose 300 mL Bag | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Amoxicillin Powder for Oral Suspension, USP safely and effectively. See full prescribing information for Amoxicillin Powder for Oral Suspension, USP. Amoxicillin Powder for Oral Suspension, USP Dye free Rx Only Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to trea | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Amoxicillin Powder for Oral Suspension, USP safely and effectively. See full prescribing information for Amoxicillin Powder for Oral Suspension, USP. Amoxicillin Powder for Oral Suspension, USP Dye free Rx Only Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to trea | 4 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | These highlights do not include all the information needed to use Megace ES safely and effectively. See full prescribing information for Megace ES. Megace ES (megestrol acetate, USP) Oral Suspension Initial U.S. Approval: 1993 ® ® ® | 3 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | These highlights do not include all the information needed to use meloxicam safely and effectively. See full prescribing information for meloxicam. meloxicam (meloxicam) TABLET for ORAL use. Initial U.S. Approval: 2000 | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | FLUCONAZOLE Fluconazole Tablets Fluconazole for Oral Suspension | 13 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | These highlights do not include all the information needed to use amoxicillin for oral suspension safely and effectively. See full prescribing information for amoxicillin for oral suspension, USP. Amoxicillin for Oral Suspension, USP Initial U.S. Approval: 1974 | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | 9537c172-fa24-4405-87db-7b7793934fb9 | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | These highlights do not include all the information needed to use meloxicam tablets USP safely and effectively. See full prescribing information for meloxicam tablets USP. MELOXICAM tablets USP for oral use Initial U.S. Approval: 2000 | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | These highlights do not include all the information needed to use meloxicam safely and effectively. See full prescribing information for meloxicam tablets. Meloxicam Tablets, USP Initial U.S. Approval: 2000 | 1 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | Allergy | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | These highlights do not include all the information needed to use Meloxicam Tablets USP safely and effectively. See full prescribing information for Meloxicam Tablets USP Meloxicam Tablets USP Initial U.S. Approval: 2000 | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | These highlights do not include all the information needed to use budesonide inhalation suspension safely and effectively. See full prescribing information for budesonide inhalation suspension. BUDESONIDE inhalation suspension Initial U.S. Approval: 2000 | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | Albuterol Sulfate Syrup | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | Dorzolamide HCl Ophthalmic Solution, 2% | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | Ganite® (gallium nitrate injection) | 4 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | Meloxicam | 6 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | PROMETHAZINE SYRUP PLAIN 6.25 mg/5 mL (Promethazine Hydrochloride Syrup, USP) | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | Amoxicillin for Oral Suspension, USP | 3 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | PRESCRIBING INFORMATION ONDANSETRON INJECTION USP | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | Albuterol Sulfate Syrup | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | f8035130-1a60-4ba3-a9be-b1a739c946db | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | a360d43c-bed8-4f41-ab36-e2aa77dfbff2 | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | Meloxicam 7.5 mg These highlights do not include all the information needed to use MOBIC safely and effectively. See full prescribing information for MOBIC. Mobic (meloxicam) tablets Mobic (meloxicam) oral suspension Initial U.S. Approval: 2000 | 12 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | These highlights do not include all the information needed to use meloxicam tablets safety and effectively. See full prescribing information for meloxicam tablets Initial U.S. Approval: 2000 | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | AMOXICILLIN powder, for suspension | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | CEFDINIR FOR ORAL SUSPENSION | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | These highlights do not include all the information needed to use meloxicam tablets USP safely and effectively. See full prescribing information for meloxicam tablets USP. MELOXICAM tablets USP for oral use Initial U.S. Approval: 2000 | 1 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | e6731360-a309-1652-6c43-5235076c18a4 | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | fe8480c4-b176-45ae-b4d6-fa59912fe286 | 4 | |
| TRISODIUM CITRATE DIHYDRATE | ACTIVE INGREDIENT | B22547B95K | Drug Facts | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | COSOPT ® (dorzolamide hydrochloride-timolol maleate ophthalmic solution) Sterile Ophthalmic Solution | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | METFORMIN HYDROCHLORIDE | 2 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | CEFDINIR FOR ORAL SUSPENSION | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | CLEANSE AND TREAT | 2 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | PHENYTOIN ORAL SUSPENSION, USP (Not for Parenteral Use) | 2 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | PHENYTOIN ORAL SUSPENSION, USP (Not for Parenteral Use) | 1 | |
| sodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | c8683c04-0e54-4e97-992b-55c2d605793c | 3 | |
| sodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | MELOXICAM TABLETS 7.5 mg and 15 mg Rx only ATTENTION DISPENSER: Accompanying Medication Guide must be dispensed with this product. | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ONDANSETRON INJECTION [CARDINAL HEALTH] | 188557104 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | MELOXICAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3914 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED ISENTRESS (RALTEGRAVIR) TABLET, CHEWABLE ISENTRESS (RALTEGRAVIR) GRANULE, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] | 49 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] | 33 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG] | 27 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | CELLCEPT (MYCOPHENOLATE MOFETIL) TABLET, FILM COATED CELLCEPT (MYCOPHENOLATE MOFETIL) CAPSULE CELLCEPT (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CELLCEPT (MYCOPHENOLATE MOFETIL) POWDER, FOR SUSPENSION [GENENTECH, INC.] | 26 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | CINRYZE (HUMAN C1-ESTERASE INHIBITOR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [VIROPHARMA BIOLOGICS] | 23 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | DIFLUCAN (FLUCONAZOLE) TABLET DIFLUCAN (FLUCONAZOLE) POWDER, FOR SUSPENSION [ROERIG] | 22 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | NOXAFIL (POSACONAZOLE) SUSPENSION NOXAFIL (POSACONAZOLE) TABLET, COATED NOXAFIL (POSACONAZOLE) SOLUTION [MERCK SHARP & DOHME CORP.] | 22 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | TEMODAR (TEMOZOLOMIDE) CAPSULE TEMODAR (TEMOZOLOMIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 22 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ONDANSETRON HYDROCHLORIDE INJECTION [LANNETT COMPANY, INC.] | 20 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | TECHNETIUM TC 99M SESTAMIBI INJECTION [MALLINCKRODT INC.] | 18 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | FLUCONAZOLE TABLET FLUCONAZOLE POWDER, FOR SUSPENSION [GREENSTONE LLC] | 17 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ZIAGEN (ABACAVIR SULFATE) TABLET, FILM COATED ZIAGEN (ABACAVIR SULFATE) SOLUTION [VIIV HEALTHCARE COMPANY] | 17 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | AMOXICILLIN POWDER, FOR SUSPENSION [WEST-WARD PHARMACEUTICAL CORP] | 16 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | BROVANA (ARFORMOTEROL TARTRATE) SOLUTION [SUNOVION PHARMACEUTICALS INC.] | 16 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM) INJECTION, SOLUTION [HOSPIRA, INC.] | 16 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | KEPPRA (LEVETIRACETAM) TABLET, FILM COATED KEPPRA (LEVETIRACETAM) SOLUTION [UCB, INC.] | 16 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | ADCETRIS (BRENTUXIMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEATTLE GENETICS, INC.] | 15 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ANALPRAM E (HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE) CREAM [FERNDALE LABORATORIES, INC.] | 15 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | MELOXICAM TABLET [INTERNATIONAL LABORATORIES, INC.] | 15 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ZOFRAN (ONDANSETRON HYDROCHLORIDE) INJECTION [GLAXOSMITHKLINE LLC] | 15 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.] | 14 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | EPIVIR HBV (LAMIVUDINE) TABLET, FILM COATED EPIVIR HBV (LAMIVUDINE) SOLUTION [GLAXOSMITHKLINE LLC] | 14 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | LEVETIRACETAM SOLUTION [AUROBINDO PHARMA LIMITED] | 14 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | PHENYLEPHRINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 14 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | RITUXAN (RITUXIMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 14 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | ZALTRAP (ZIV-AFLIBERCEPT) SOLUTION, CONCENTRATE [SANOFI-AVENTIS U.S. LLC] | 14 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | CARDIOLITE (TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [LANTHEUS MEDICAL IMAGING, INC.] | 13 | |
| Trisodium Citrate Dihydrate | ACTIVE INGREDIENT | B22547B95K | CPD/ADSOL (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 13 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | FOLLISTIM AQ (FOLLITROPIN) INJECTION, SOLUTION [ORGANON USA INC.] | 13 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ONDANSETRON INJECTION [WEST-WARD PHARMACEUTICALS CORP] | 13 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | TRULICITY (DULAGLUTIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 13 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ARTISS (FIBRINOGEN HUMAN THROMBIN HUMAN) KIT ARTISS FROZEN (FIBRINOGEN HUMAN THROMBIN HUMAN) SOLUTION [BAXTER HEALTHCARE CORPORATION] | 12 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ARTISS FROZEN (FIBRINOGEN HUMAN THROMBIN HUMAN) SOLUTION ARTISS (FIBRINOGEN HUMAN THROMBIN HUMAN) KIT [BAXTER HEALTHCARE CORPORATION] | 12 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | FLUCONAZOLE POWDER, FOR SUSPENSION [AUROBINDO PHARMA LIMITED] | 12 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | MELOXICAM TABLET [AUROBINDO PHARMA LIMITED] | 12 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | NALBUPHINE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 12 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | PERFOROMIST (FORMOTEROL FUMARATE DIHYDRATE) SOLUTION [MYLAN SPECIALTY L.P.] | 12 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE SYRUP [HI-TECH PHARMACAL CO., INC.] | 12 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | VPRIV (VELAGLUCERASE ALFA) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SHIRE US MANUFACTURING INC.] | 12 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ARTISS (FIBRINOGEN HUMAN THROMBIN HUMAN) KIT ARTISS FROZEN (FIBRINOGEN HUMAN THROMBIN HUMAN) SOLUTION [BAXTER HEALTHCARE CORPORATION] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | BUTORPHANOL TARTRATE INJECTION, SOLUTION [HOSPIRA, INC.] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | DOPAMINE HYDROCHLORIDE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | EPIVIR (LAMIVUDINE) TABLET, FILM COATED EPIVIR (LAMIVUDINE) SOLUTION [VIIV HEALTHCARE COMPANY] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | LEVETIRACETAM SOLUTION [HI-TECH PHARMACAL CO., INC.] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | MELOXICAM TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | METHADOSE (METHADONE HYDROCHLORIDE) CONCENTRATE METHADOSE SUGAR-FREE (METHADONE HYDROCHLORIDE) CONCENTRATE [MALLINCKRODT, INC.] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | OMIDRIA (PHENYLEPHRINE AND KETOROLAC) INJECTION, SOLUTION, CONCENTRATE [OMEROS CORPORATION] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ONDANSETRON INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ONDANSETRON INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ONDANSETRON INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ONDANSETRON INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | OXYCODONE HYDROCHLORIDE SOLUTION [LEHIGH VALLEY TECHNOLOGIES, INC.] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | AZITHROMYCIN TABLET, FILM COATED [PLIVA, INC.] | 10 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | BUPRENORPHINE HYDROCHLORIDE TABLET [HI-TECH PHARMACAL CO., INC.] | 10 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | DILTIAZEM HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 10 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | MEGACE ES (MEGESTEROL ACETATE) SUSPENSION [PAR PHARMACEUTICAL, INC] | 10 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | MYCOPHENOLATE MOFETIL POWDER, FOR SUSPENSION [ASCEND LABORATORIES, LLC] | 10 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | ALINIA (NITAZOXANIDE) TABLET ALINIA (NITAZOXANIDE) POWDER, FOR SUSPENSION [ROMARK LABORATORIES, LC] | 9 | |
| Trisodium Citrate Dihydrate | ACTIVE INGREDIENT | B22547B95K | CPD/ADSOL RED CELL PRESERVATION SOLUTION SYSTEM (PL 2209) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 9 | |
| Trisodium Citrate Dihydrate | ACTIVE INGREDIENT | B22547B95K | CPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.] | 9 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | DORZOLAMIDE HYDROCHLORIDE SOLUTION/ DROPS [SANDOZ INC.] | 9 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | FOLLISTIM AQ (FOLLITROPIN) INJECTION, SOLUTION [ORGANON USA INC.] | 9 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | LEVETIRACETAM TABLET, FILM COATED LEVETIRACETAM SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 9 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | MELOXICAM TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 9 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | MELOXICAM TABLET [TEVA PHARMACEUTICALS USA INC] | 9 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | MOBIC (MELOXICAM) TABLET [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | NATRECOR (NESIRITIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SCIOS LLC] | 9 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) SOLUTION [AUROBINDO PHARMA LIMITED] | 9 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | TRUSOPT (DORZOLAMIDE HYDROCHLORIDE) SOLUTION [MERCK SHARP & DOHME CORP.] | 9 | |
| trisodium citrate dihydrate | INACTIVE INGREDIENT | B22547B95K | ACUVAIL (KETOROLAC TROMETHAMINE) SOLUTION/ DROPS [ALLERGAN, INC.] | 8 | |
| Trisodium Citrate Dihydrate | ACTIVE INGREDIENT | B22547B95K | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 8 | |
| Trisodium Citrate Dihydrate | ACTIVE INGREDIENT | B22547B95K | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 8 | |
| Trisodium Citrate Dihydrate | ACTIVE INGREDIENT | B22547B95K | ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 8 | |